Continuing Medical Education Information

 

 MOOD DISORDERS IN CHILDREN AND ADOLESCENTS: 

AN EVIDENCE-BASED UPDATE ON DIAGNOSIS AND TREATMENT

Date and Location:      January 20, 2024  Webinar

                                                                                       

Target Audience:  Child and adolescent psychiatrists and other clinicians

 

Program Overview:                                                      

This program will consist of six talks—covering mood disorders from childhood through transitional age—and--from diagnosis to brain mechanisms to treatment. Therapeutic approaches to be discussed include established (neurotherapeutic), evolving (ketamine), and potential interventions (psychedelics).  There will be plenty of time for interactive questions.

Planners and Faculty:

Melissa A. Brotman, PhD – Content Developer, Speaker

Dr. Brotman does not have any relevant financial relationships with ineligible companies to disclose.

Daniel Dickstein, MD – Content Developer, Speaker

Dr. Dickstein does not have any relevant financial relationships with ineligible companies to disclose.

Robert Meisner, MD – Content Developer, Speaker

Dr. Meisner does not have any relevant financial relationships with ineligible companies to disclose.

Brian Skehan, MD, PhD - Content Developer, Speaker

Dr. Skehan does not have any relevant financial relationships with ineligible companies to disclose.

Robyn P. Thom, MD – Content Developer, Speaker

Dr. Thom does not have any relevant financial relationships with ineligible companies to disclose.

Mai Uchida, MD – Content Developer, Speaker

Dr. Uchida does not have any relevant financial relationships with ineligible companies to disclose.

Sharon Weinstein, MD – Planner, Content Developer

Dr. Weinstein does not have any relevant financial relationships with ineligible companies to disclose.

 Educational Objectives

 After attending this live seminar, attendees will be able to:

 

·       Communicate with patients and their families about the meaning and importance of evidence-based, data-driven, “safety-first” care.

·       Discuss strategies to modify existing evidence-based psychotherapies for youth with autism spectrum disorder.

·       Discuss the potential mechanism of exposure-based cognitive behavioral therapy for irritability.

·       Understand the various models of care on college campuses and opportunities for collaboration.

·       Understand neuroimaging-based identifiers of children at risk for bipolar disorder while presenting with depression.

Accreditation Statement

Professional Risk Management Services (PRMS) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

 MA Credit Designation Statement

Professional Risk Management Services (PRMS) designates this live activity for a maximum of 3.5 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest

PRMS does not accept financial support from ineligible companies for CME activities.  

Method of Participation

Physicians must attend the live activity and complete a Post Activity Learning Assessment Tool and Credit Application form to receive a Credit Certificate. 

Estimated Time to Complete

3.5 hours